Brackmann Christoph
SEC CIK 2048634 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NVCR | NovoCure Ltd | CFO | 182.8K | $231.8K | $85.3K | 5 | 2025-03-04 | 2026-03-04 |
Most active insiders at NVCR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DOYLE WILLIAM F | Executive COB, Dir | — | $933.1K |
| 2 | Leonard Frank X | EVP, Pres, Novocure Oncology | — | $919.8K |
| 3 | Paravasthu Mukund | COO | — | $693.8K |
| 4 | Weinberg Uri | Chf Medical, Innovation Ofr | — | $232.2K |
| 5 | Brackmann Christoph | CFO | — | $85.3K |
| 6 | Stafford Kristin | Dir | — | $46.4K |
| 7 | Ocean Allyson J | Dir | — | $46.4K |
| 8 | Scannell Timothy J | Dir | — | $46.4K |
| 9 | VERNON W ANTHONY | Dir | — | $46.4K |
| 10 | Hung David | Dir | — | $46.4K |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-05 | 2026-03-04 | NVCR | NovoCure Ltd | Brackmann Christoph | CFO | S - Sale | $13.31 | -6,412 | 182.8K | -3% | -$85.3K |
| D | 2026-03-05 | 2026-03-03 | NVCR | NovoCure Ltd | Brackmann Christoph | CFO | A - Grant | $0.00 | +55.1K | 189.3K | +41% | $0 |
| 2025-11-04 | 2025-11-04 | NVCR | NovoCure Ltd | Brackmann Christoph | CFO | F - Tax | $12.23 | -7,033 | 134.1K | -5% | -$86.0K | |
| M | 2025-07-30 | 2025-07-29 | NVCR | NovoCure Ltd | Brackmann Christoph | CFO | P - Purchase | $11.59 | +20.0K | 136.2K | +17% | +$231.8K |
| D | 2025-03-06 | 2025-03-04 | NVCR | NovoCure Ltd | Brackmann Christoph | CFO | A - Grant | $18.19 | +55.0K | 121.2K | +83% | +$1000.0K |
Purchase Sale Sale after option exercise All abbreviations